Clinical Trial: Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic Efficacy

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT07574749) titled 'Molecular Subtyping of Breast Cancer-derived Small Extracellular Vesicles (sEVs) to Predict Therapeutic Efficacy' on Feb. 02.

Brief Summary: The goal of this observational study is to learn if a new diagnostic test using specific labels for breast cancer sEVs on a microchip can accurately diagnose the molecular subtypes in patients with breast cancer. The main questions it aims to answer are:

* What is the sensitivity of this new sEVs-based panel for diagnosing breast cancer molecular subtypes?

* What is the specificity of this new sEVs-based panel for diagnosing breast cancer molecular subtypes? Researchers will compare the results...